The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Janssen Research & Development
Analysis of infections and parameters of humoral immunity in patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with talquetamab (tal) monotherapy in MonumenTAL-1.
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Carolina D. Schinke
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Research Funding - Janssen
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda
 
Brea Lipe
Consulting or Advisory Role - Bristol Meyers; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Amgen (Inst); Celgene (Inst); cellectar (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Seagen (Inst)
 
Noa Lavi
No Relationships to Disclose
 
Leo Rasche
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer (I); Sanofi
Research Funding - Bristol-Myers Squibb; Skyline Diagnostics
 
Deeksha Vishwamitra
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Sheri Skerget
Employment - Janssen
 
Raluca Verona
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Johnson & Johnson
Other Relationship - Johnson & Johnson
 
Xuewen Ma
Employment - Johnson & Johnson/Janssen; Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Sheetal Khedkar
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Brandi Hilder
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen
 
Tara J. Masterson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Michela Campagna
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Thomas Renaud
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Jaszianne A. Tolbert
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Johnson & Johnson
Research Funding - Janssen Research & Development
 
Christoph Heuck
No Relationships to Disclose
 
Marie-Anne Damiette Smit
Employment - Amgen; Janssen Biologics BV; Johnson & Johnson
Stock and Other Ownership Interests - Amgen; Johnson & Johnson
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)